| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.33B | -6.3% |
| R&D Expense | $49.0M | -5.8% |
| SG&A Expense | $313.0M | -1.3% |
| Interest Expense | $111.0M | +0.0% |
| Pre-tax Income | $135.0M | -41.8% |
| Income Tax | $75.0M | +0.0% |
| Net Income | $56.0M | -63.2% |
| EPS (Basic) | $0.38 | -63.5% |
| EPS (Diluted) | $0.38 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $141.0M | -36.8% |
| Accounts Receivable | $381.0M | -8.9% |
| Inventory | $1.18B | -1.3% |
| Current Assets | $1.83B | -7.9% |
| Total Assets | $4.73B | -4.0% |
| Current Liabilities | $1.45B | -7.1% |
| Long-term Debt | $1.88B | -0.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $301.0M | -30.3% |
| Capital Expenditures | $413.0M | +12.8% |
| Investing Cash Flow | -$313.0M | -44.9% |
| Financing Cash Flow | -$61.0M | +65.5% |
| Free Cash Flow | -$112.0M | -269.7% |
| -63.1% |
| Total Liabilities |
| $4.01B |
| -4.4% |
| Stockholders' Equity | $706.0M | -1.7% |